Summary
Updated Aug 31, 2026
Daniel S. Lorrain is Chief Scientific Officer of Contineum Therapeutics, Inc. (CTNM). 13 SEC Form 4 filings on record going back to 2024, most recently on 10 July 2026. Most recent open-market trade: sold $400 of CTNM on 10 July 2026. Lifetime open-market sales: $1.16M.
Recent Transactions
20Every recent SEC Form 4 transaction Daniel S. Lorrain has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Daniel S. Lorrain go back to 2024: 13 primary Form 4 filings, an average of 4.3 per year. 35 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Daniel S. Lorrain files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Carmine N. Stengone - $360K of CTNM open-market activity in the last 12 months
- Tim Watkins - $279K of CTNM open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Daniel S. Lorrain?
Daniel S. Lorrain is a corporate insider, tracked as Chief Scientific Officer of Contineum Therapeutics, Inc. (CTNM). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Daniel S. Lorrain submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Daniel S. Lorrain been buying or selling stock?
Recorded transactions: 0 open-market purchases and 19 open-market sales ($1.16M) across all tracked filings.
Where can I see all of Daniel S. Lorrain's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Daniel S. Lorrain and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial